These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 31092603)

  • 1. Disarming Pore-Forming Toxins with Biomimetic Nanosponges in Intraocular Infections.
    Coburn PS; Miller FC; LaGrow AL; Land C; Mursalin H; Livingston E; Amayem O; Chen Y; Gao W; Zhang L; Callegan MC
    mSphere; 2019 May; 4(3):. PubMed ID: 31092603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Biomimetic Nanosponge Protects the Retina from the
    LaGrow AL; Coburn PS; Miller FC; Land C; Parkunan SM; Luk BT; Gao W; Zhang L; Callegan MC
    mSphere; 2017; 2(6):. PubMed ID: 29202038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of CCL2 and CCL3 in intraocular inflammation during Bacillus endophthalmitis.
    Mursalin MH; Astley R; Coburn PS; Miller FC; Callegan MC
    Exp Eye Res; 2022 Nov; 224():109213. PubMed ID: 36063964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of gram-positive bacterial endophthalmitis.
    Callegan MC; Booth MC; Jett BD; Gilmore MS
    Infect Immun; 1999 Jul; 67(7):3348-56. PubMed ID: 10377112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward improving therapeutic regimens for Bacillus endophthalmitis.
    Wiskur BJ; Robinson ML; Farrand AJ; Novosad BD; Callegan MC
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1480-7. PubMed ID: 18385066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad-Spectrum Neutralization of Pore-Forming Toxins with Human Erythrocyte Membrane-Coated Nanosponges.
    Chen Y; Chen M; Zhang Y; Lee JH; Escajadillo T; Gong H; Fang RH; Gao W; Nizet V; Zhang L
    Adv Healthc Mater; 2018 Jul; 7(13):e1701366. PubMed ID: 29436150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes.
    Major JC; Engelbert M; Flynn HW; Miller D; Smiddy WE; Davis JL
    Am J Ophthalmol; 2010 Feb; 149(2):278-283.e1. PubMed ID: 19926069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains.
    Jett BD; Jensen HG; Atkuri RV; Gilmore MS
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):9-15. PubMed ID: 7822163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
    De Kaspar HM; Ta CN; Engelbert M; Mette M; Thiel M; Kampik A
    Retina; 2008 Feb; 28(2):326-32. PubMed ID: 18301039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens.
    Callegan MC; Ramirez R; Kane ST; Cochran DC; Jensen H
    Adv Ther; 2003; 20(5):246-52. PubMed ID: 14964344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular dexamethasone produces a harmful effect on treatment of experimental Staphylococcus aureus endophthalmitis.
    Meredith TA; Aguilar HE; Drews C; Sawant A; Gardner S; Wilson LA; Grossniklaus HE
    Trans Am Ophthalmol Soc; 1996; 94():241-52; discussion 252-7. PubMed ID: 8981699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics.
    Lefèvre S; Saleh M; Marcellin L; Subilia A; Bourcier T; Prévost G; Jehl F
    Antimicrob Agents Chemother; 2012 May; 56(5):2485-92. PubMed ID: 22371888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcus aureus and its Bearing on Ophthalmic Disease.
    Sadaka A; Durand ML; Sisk R; Gilmore MS
    Ocul Immunol Inflamm; 2017 Feb; 25(1):111-121. PubMed ID: 26679534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-X-C Chemokines Influence Intraocular Inflammation During Bacillus Endophthalmitis.
    Mursalin MH; Coburn PS; Miller FC; Livingston ET; Astley R; Callegan MC
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):14. PubMed ID: 34784411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose intramuscular methylprednisolone in experimental Staphylococcus aureus endophthalmitis.
    Yoshizumi MO; Kashani A; Palmer J; Lee G; Mondino B
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):91-6. PubMed ID: 10048352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methicillin-resistant Staphylococcus aureus infections after scleral buckling procedures for retinal detachments associated with atopic dermatitis.
    Oshima Y; Ohji M; Inoue Y; Harada J; Motokura M; Saito Y; Emi K; Tano Y
    Ophthalmology; 1999 Jan; 106(1):142-7. PubMed ID: 9917795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus in ocular infections.
    Vola ME; Moriyama AS; Lisboa R; Vola MM; Hirai FE; Bispo PJ; Höfling-Lima AL
    Arq Bras Oftalmol; 2013; 76(6):350-3. PubMed ID: 24510081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit.
    Dajcs JJ; Thibodeaux BA; Hume EB; Zheng X; Sloop GD; O'Callaghan RJ
    Curr Eye Res; 2001 Jun; 22(6):451-7. PubMed ID: 11584345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Toll-like receptor (TLR) 2 in experimental Bacillus cereus endophthalmitis.
    Novosad BD; Astley RA; Callegan MC
    PLoS One; 2011; 6(12):e28619. PubMed ID: 22163046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of
    Mursalin MH; Astley R; Coburn PS; Bagaruka E; Hunt JJ; Fischetti VA; Callegan MC
    mSphere; 2023 Aug; 8(4):e0004423. PubMed ID: 37273201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.